On the contrary, analysis on a fresh breast tumor biopsy, by flow cytometry, revealed that IL-17RB was expressed by the EpCAM+ Cytokeratin+ tumor cells and by some fibroblasts, but also immune subpopulations within the tumor microenvironment (Figure 2B). Here, IL17RB is linked to breast neoplasm.